Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01536496 · ClinicalTrials.gov registry record · NA
Comparison of Rapid Thrombelastography and Conventional Coagulation Testing for Haemostatic Resuscitation in Trauma
A NA study, sponsored by Denver Health and Hospital Authority.
- Completed
- Registry status
- NA
- Development phase
- 114
- Enrollment target
NCT01536496 is a NA study that has completed, run by Denver Health and Hospital Authority. The registered enrollment target is 114 participants.
The verdict
NCT01536496, a NA study, has completed, sponsored by Denver Health and Hospital Authority.
- COMPLETED
- Registry status
- NA
- Development phase
- 114 participants
- Enrollment target
Study Summary
The purpose of this study is to compare rapid thrombelastography (r-TEG) with conventional coagulation testing for diagnosing and treating coagulation abnormalities in severely injured patients who are likely to require transfusion therapy.
Interventions
- BIOLOGICAL Blood product transfusion based on conventional coagulation tests.
- BIOLOGICAL Blood product transfusion based on rapid thrombelastography (r-TEG) results.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2010-09 |
| Est. Completion | 2014-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01536496
The ClinicalTrials.gov registry entry for NCT01536496 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 114 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Denver Health and Hospital Authority, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Blood product transfusion based on conventional coagulation tests. is the first listed.
NCT01536496 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01536496 about?
NCT01536496 is a clinical study titled "Comparison of Rapid Thrombelastography and Conventional Coagulation Testing for Haemostatic Resuscitation in Trauma". The purpose of this study is to compare rapid thrombelastography (r-TEG) with conventional coagulation testing for diagnosing and treating coagulation abnormalities in severely injured patients who are likely to require transfusion therapy.
What is the current status of trial NCT01536496?
This trial is currently completed. It is a NA study. The enrollment target is 114 participants. The study started on 2010-09. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01536496?
The interventions under investigation include: Blood product transfusion based on conventional coagulation tests. (BIOLOGICAL), Blood product transfusion based on rapid thrombelastography (r-TEG) results. (BIOLOGICAL).
Who is sponsoring clinical trial NCT01536496?
This trial is sponsored by Denver Health and Hospital Authority, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.